USF Breast Health Program Trials

USF Breast Health Program	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Cox, Charles E

MATIC-2, NCT06070350: Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children

Recruiting

1000

Low Titer Group O Whole Blood (LTOWB), Placebo, Tranexamic Acid (TXA), Component Therapy (CT)

Philip Spinella, Biomedical Advanced Research and Development Authority

Hemorrhagic Shock, Trauma Injury

06/28

10/28

NCT04533464: MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome

Recruiting

156

MultiStem, Placebo

Healios K.K., Memorial Hermann Hospital, United States Department of Defense

Trauma, Adult Stem Cells

12/25

NCT02525432: Autologous Stem Cell Study for Adult TBI (Phase 2b)

Active, not recruiting

Placebo Infusion, Autologous BMMNC Infusion, Stem Cell Infusion

The University of Texas Health Science Center, Houston, United States Department of Defense, U.S. Army Medical Research and Development Command

Brain Injuries, Traumatic, Brain Injuries, Acute, TBI (Traumatic Brain Injury)

07/24

01/25

NCT05951777: Autologous Adipose Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Recruiting

Autologous HB-adMSCs, Normal Saline

Hope Biosciences, The University of Texas Health Science Center, Houston

Traumatic Brain Injury

12/26

NCT04063215: A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy

Completed

1/2

HB-adMSCs

Hope Biosciences, The University of Texas Health Science Center, Houston

Traumatic Brain Injury

10/24

NCT06654193: Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury

Not yet recruiting

1/2

Allogeneic HB-adMSCs, Normal Saline

Hope Biosciences, The University of Texas Health Science Center, Houston, University of California, San Francisco, University of Alabama at Birmingham

Acute Kidney Injury

01/28

COVID-19, NCT06156241: Stem Cell Study for Long Neurological Symptoms

Not yet recruiting

Stem Cell, Allogenic Human Cord Tissue Derived Mesenchymal Stromal Cells (hCTMSCs)

Charles Cox, CBR Systems, Inc.

Post-Acute COVID-19 Syndrome

12/25

02/26

NCT03203941: ACT for CP Individual Patient Expanded Access IND Protocol

No Longer Available

N/A

Autologous Cord Blood Stem Cells

Charles Cox

Cerebral Palsy

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

FLEX, NCT03053193: MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Recruiting

N/A

30000

Europe, Canada, US, RoW

MammaPrint, BluePrint, and Full-Genome Testing, MammaPrint, BluePrint

Agendia

Breast Cancer

04/37

12/37

Pernicone, Meira

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

Greenberg, Harvey

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

Beard, Abby

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

Hechtman, Jason

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

Trotman, Al'Lima

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

FLEX, NCT03053193: MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Recruiting

N/A

30000

Europe, Canada, US, RoW

MammaPrint, BluePrint, and Full-Genome Testing, MammaPrint, BluePrint

Agendia

Breast Cancer

04/37

12/37

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Cox, Charles E

MATIC-2, NCT06070350: Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children

Recruiting

1000

Low Titer Group O Whole Blood (LTOWB), Placebo, Tranexamic Acid (TXA), Component Therapy (CT)

Philip Spinella, Biomedical Advanced Research and Development Authority

Hemorrhagic Shock, Trauma Injury

06/28

10/28

NCT04533464: MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome

Recruiting

156

MultiStem, Placebo

Healios K.K., Memorial Hermann Hospital, United States Department of Defense

Trauma, Adult Stem Cells

12/25

NCT02525432: Autologous Stem Cell Study for Adult TBI (Phase 2b)

Active, not recruiting

Placebo Infusion, Autologous BMMNC Infusion, Stem Cell Infusion

The University of Texas Health Science Center, Houston, United States Department of Defense, U.S. Army Medical Research and Development Command

Brain Injuries, Traumatic, Brain Injuries, Acute, TBI (Traumatic Brain Injury)

07/24

01/25

NCT05951777: Autologous Adipose Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Recruiting

Autologous HB-adMSCs, Normal Saline

Hope Biosciences, The University of Texas Health Science Center, Houston

Traumatic Brain Injury

12/26

Completed

1/2

HB-adMSCs

Hope Biosciences, The University of Texas Health Science Center, Houston

Traumatic Brain Injury

10/24

NCT06654193: Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury

Not yet recruiting

1/2

Allogeneic HB-adMSCs, Normal Saline

Hope Biosciences, The University of Texas Health Science Center, Houston, University of California, San Francisco, University of Alabama at Birmingham

Acute Kidney Injury

01/28

COVID-19, NCT06156241: Stem Cell Study for Long Neurological Symptoms

Not yet recruiting

Stem Cell, Allogenic Human Cord Tissue Derived Mesenchymal Stromal Cells (hCTMSCs)

Charles Cox, CBR Systems, Inc.

Post-Acute COVID-19 Syndrome

12/25

02/26

NCT03203941: ACT for CP Individual Patient Expanded Access IND Protocol

No Longer Available

N/A

Autologous Cord Blood Stem Cells

Charles Cox

Cerebral Palsy

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

FLEX, NCT03053193: MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Recruiting

N/A

30000

Europe, Canada, US, RoW

MammaPrint, BluePrint, and Full-Genome Testing, MammaPrint, BluePrint

Agendia

Breast Cancer

04/37

12/37

Pernicone, Meira

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

Greenberg, Harvey

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

Beard, Abby

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

Hechtman, Jason

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

Trotman, Al'Lima

PREDICT, NCT03448926: The Registry:

Recruiting

N/A

3000

Treatment Recommendation Surveys, 7-gene biosignature

PreludeDx, University of South Florida

DCIS

12/25

12/35

FLEX, NCT03053193: MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Recruiting

N/A

30000

Europe, Canada, US, RoW

MammaPrint, BluePrint, and Full-Genome Testing, MammaPrint, BluePrint

Agendia

Breast Cancer

04/37

12/37



	Diseases Companies Products Productz Mechanisms of Action Sites